Drug Search Results
More Filters [+]

Primidone

Alternative Names: primidone, mysoline
Latest Update: 2024-07-12
Latest Update Note: News Article

Product Description

Primidone is an aromatic anticonvulsant used to treat complex, partial, and generalized seizures. (Sourced from: https://www.ncbi.nlm.nih.gov/books/NBK562297/)

Mechanisms of Action: GABA Modulator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Canada | Chile | China | Colombia | Czech | Estonia | France | Germany | Greece | Hungary | India | Ireland | Israel | Italy | Korea | Lithuania | Luxembourg | Malta | Mexico | Netherlands | New Zealand | Pakistan | Peru | Poland | Portugal | Russia | Slovenia | South Africa | Spain | Sri Lanka | Switzerland | Taiwan | Turkey | United Kingdom | United States | Uruguay | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Primidone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events